AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win

AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win

Submitted by admin on November 15, 2018 - 11:39pm
Source: 
Fierce Pharma
News Tags: 
AbbVie
Orilissa
FDA
uterine fibroids
Neurocrine
Headline: 
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
snippet: 

AbbVie’s Orilissa snagged its first FDA approval over the summer, and now it’s looking to make it two. 

Do Not Allow Advertisers to Use My Personal information